<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02087735</url>
  </required_header>
  <id_info>
    <org_study_id>PACS-2013-SD</org_study_id>
    <nct_id>NCT02087735</nct_id>
  </id_info>
  <brief_title>Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts</brief_title>
  <acronym>CUPACS</acronym>
  <official_title>Measurement of Urinary Catabolites of the Proanthocyanidines (PACs) in Healthy Young Women as Biomarkers of Consumption of Cranberry Extracts.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this cross over pilot study is to investigate the urinary catabolites of
      Proanthocyanidines (PACs) as biomarkers of cranberry extracts in healthy young women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary catabolites of PACs</measure>
    <time_frame>within 9 hours following the intake of cranberry extracts</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>cranberry extract 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One capsule with a proanthocyanidin standardized cranberry extract of 36 mg and one capsule of placebo cranberry extract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cranberry extract 2.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two capsules with a proanthocyanidin standardized cranberry extract of 36 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cranberry extract 3.</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two capsules with a proanthocyanidin standardized cranberry extract of 2 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry extract</intervention_name>
    <description>The aim of this pilot study is to evaluate the urinary catabolites of PACs as a biomarker of consumption of cranberry extracts within 9 hours of intercourse. Once a week, for 3 weeks, the women will receive a sequence of 3 different cranberry extracts (72 mg, 36 mg and 2mg (placebo)). The participant will have to collect its urine for a period of 9 hours in 3 different containers (one different container for 3 hours).</description>
    <arm_group_label>cranberry extract 1</arm_group_label>
    <arm_group_label>cranberry extract 2.</arm_group_label>
    <arm_group_label>cranberry extract 3.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy women.

          -  18 to 40 years.

        Exclusion Criteria:

          -  No internet access.

          -  No refrigerator access during the 9 hours of sample collection.

          -  Women who had or expect to take antibiotic.

          -  Women who had or expect to take cranberries, blueberries or bilberries in the form of
             berries, juice or extracts.

          -  Women who had or expect to take dark chocolate.

          -  Women who had personal history of acute or chronic renal failure.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvie Dodin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laval University, Department of Medecine, Institut sur la nutrition et les aliments fonctionnels (INAF).</name>
      <address>
        <city>Qu√©bec</city>
        <state>Quebec</state>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2014</study_first_submitted>
  <study_first_submitted_qc>March 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2014</study_first_posted>
  <last_update_submitted>October 7, 2016</last_update_submitted>
  <last_update_submitted_qc>October 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Sylvie Dodin</investigator_full_name>
    <investigator_title>Sylvie Dodin, MD</investigator_title>
  </responsible_party>
  <keyword>Cranberry</keyword>
  <keyword>Proanthocyanidins</keyword>
  <keyword>Urinary catabolites</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Proanthocyanidin</mesh_term>
    <mesh_term>Procyanidin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

